Try using the wayback machine on the web to search for the original version.
These people/researchers know what they are doing and they are evil. The doctors trained are bamboozled into believing they are doing the right thing. Some now, after Covid (who came up with that name and why?) there are a few waking up.
Germ Theory, imho, is a complete lie. They had microscopes that can show the nano-details and they removed it from the market. What’s that tell you?
A controlled demolition of our society is ongoing. Weak, pathetic humans en masse . . . In general.
Thank you 🙏🏼 for your service to humanity Heidi. Shining light on darkness is your forte. Prayers you are blessed by God throughout your family in these turbulent days.
The original '96 version was different. I'm almost certain I have it from a print out. Back when I first learned about this I printed EVERYTHING. I was so afraid it would disappear. I made several copies, put them in several giant binders, gave a copy to my mom. I thought, I'm going to blow the lid off this and I want proof spread around... but I never blew the lid off. I'm banned and blocked everywhere.
I will try to find it today and upload it if I do.
Dr. Markert is still at Duke U unless she retired recently. She is part of the group who made Rethymic the drug from infant thymuses. I just found some of our emails back and forth from 2004 but not the one where she said she cannot help Daniel because there is no protocol in place. I contacted her to MAKE A PROTOCOL for the babies who's thymuses she steals and uses. It wasnt that she could not. She *would * not help. Both it and the 96' version of the article are missing. I know what I did with them. I put them somewhere else to "keep them safe" I always regret when I do this.
Just click on the first paper, 2022. Then click on "Show Details" to see the authors. On this particular paper, they're all from Duke, Department of Surgery.
The intro: "In solid-organ transplantation, one strategy for inducing tolerance has been cotransplantation of various forms of thymic tissue along with another organ."
... the thought is that if you transplant a thymus at the same time you transplant another organ like the kidneys, it helps the body accept (i.e., "tolerate" it, and not reject) it.
So it's not just the "single organ" transplant that has been attempted. The thymus has also been studied as a means to use it in "cotransplantation" to make the primary organ less likely to be rejected.
In that case, if it works, that means that virtually every transplantation would benefit from adding a thymus transplant AT THE SAME TIME.
This is HUGE. If they're using a thymus "co-transplantation" for every organ transplantation, just imagine how many thymus' they would need!
What they're doing is heart breaking. Inconceivable. Beyond a horror sci fi flick. A Robin cook book come to life. Thank you again for looking this up and sharing it. ❤
Jean Kwun 1 , Jie Li 1 , Clay Rouse 2 , Jae Berm Park 1 , Alton B Farris 3 , Maragatha Kuchibhatla 4 , Joseph W Turek 1 , Stuart J Knechtle 1 , Allan D Kirk 1 , M Louise Markert 5 6
Affiliations
1 Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
2 Division of Laboratory Animal Resources, Duke University, Durham, North Carolina, USA.
3 Department of Pathology, Emory University, Atlanta, Georgia, USA.
4 Department of Biostatistics and Bioinformatics.
5 Department of Immunology, and.
6 Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA.
PMID: 32352934
PMCID: PMC7308047
DOI: 10.1172/jci.insight.129983
** Their Conflict of Interest Statement:
Conflict of interest statement **
"Conflict of interest: Funding was obtained for this study in part from Enzyvant. MLM developed the technology of thymus transplantation, which has been licensed to Enzyvant. MLM has received royalties from Enzyvant. Portions of MLM’s and her research team’s salaries are being paid by the funding from Enzyvant. If the technology is commercially successful in the future, MLM and Duke may benefit financially."
Therapeutics, Inc. and Altavant Sciences, Inc., both wholly owned subsidiaries of the global biopharmaceutical giant Sumitovant Biopharma Ltd., today announced a merger to form a North Carolina-based biopharmaceutical company focused on delivering life-altering therapies for people with rare diseases.
The combined company retains the name Enzyvant, a company that got its start in 2016 in Durham, with a history of Triangle collaboration by manufacturing its unique products in facilities at Duke University.
So you are reaching more people than you realized !
🙏💞💞💞
Good job keeping receipts!
🙏 I've been anticipating the day they might try to hide what they've done.
Yeah tptb tend to tip their hands eh? Predictable once you see their fuckery
Try using the wayback machine on the web to search for the original version.
These people/researchers know what they are doing and they are evil. The doctors trained are bamboozled into believing they are doing the right thing. Some now, after Covid (who came up with that name and why?) there are a few waking up.
Germ Theory, imho, is a complete lie. They had microscopes that can show the nano-details and they removed it from the market. What’s that tell you?
A controlled demolition of our society is ongoing. Weak, pathetic humans en masse . . . In general.
Thank you 🙏🏼 for your service to humanity Heidi. Shining light on darkness is your forte. Prayers you are blessed by God throughout your family in these turbulent days.
Maranatha 🕊️✝️🕊️
Thank you for your prayers Suzanne. 🙏💕
The original isn't on the way back machine. I may have a printout of the original though. I will upload it later if I find it.
Pure evil! Just CONFIRMS that they have something to hide!
🎯🎯🎯🙏
Look ~ there's no author!
Wow! Observant!!
No one want to take credit?
The original '96 version was different. I'm almost certain I have it from a print out. Back when I first learned about this I printed EVERYTHING. I was so afraid it would disappear. I made several copies, put them in several giant binders, gave a copy to my mom. I thought, I'm going to blow the lid off this and I want proof spread around... but I never blew the lid off. I'm banned and blocked everywhere.
I will try to find it today and upload it if I do.
Please do find what you can. It's possible that the author(s) are still at Duke, or continuing their research at another academic institution 👌
Thank you for all your research.
Dr. Markert is still at Duke U unless she retired recently. She is part of the group who made Rethymic the drug from infant thymuses. I just found some of our emails back and forth from 2004 but not the one where she said she cannot help Daniel because there is no protocol in place. I contacted her to MAKE A PROTOCOL for the babies who's thymuses she steals and uses. It wasnt that she could not. She *would * not help. Both it and the 96' version of the article are missing. I know what I did with them. I put them somewhere else to "keep them safe" I always regret when I do this.
I did a Pubmed Search and found 3 pages of papers... can search each one for 1996 and later, focus on authors from Duke
https://pubmed.ncbi.nlm.nih.gov/?term=thymus%20implants
Just click on the first paper, 2022. Then click on "Show Details" to see the authors. On this particular paper, they're all from Duke, Department of Surgery.
The intro: "In solid-organ transplantation, one strategy for inducing tolerance has been cotransplantation of various forms of thymic tissue along with another organ."
... the thought is that if you transplant a thymus at the same time you transplant another organ like the kidneys, it helps the body accept (i.e., "tolerate" it, and not reject) it.
So it's not just the "single organ" transplant that has been attempted. The thymus has also been studied as a means to use it in "cotransplantation" to make the primary organ less likely to be rejected.
In that case, if it works, that means that virtually every transplantation would benefit from adding a thymus transplant AT THE SAME TIME.
This is HUGE. If they're using a thymus "co-transplantation" for every organ transplantation, just imagine how many thymus' they would need!
What they're doing is heart breaking. Inconceivable. Beyond a horror sci fi flick. A Robin cook book come to life. Thank you again for looking this up and sharing it. ❤
#12 on the literature search also cites Duke:
"Cultured thymus tissue implantation promotes donor-specific tolerance to allogeneic heart transplants
Jean Kwun et al. JCI Insight. 2020."
JCI Insight. 2020 Jun 4;5(11):e129983.
doi: 10.1172/jci.insight.129983.
Authors
Jean Kwun 1 , Jie Li 1 , Clay Rouse 2 , Jae Berm Park 1 , Alton B Farris 3 , Maragatha Kuchibhatla 4 , Joseph W Turek 1 , Stuart J Knechtle 1 , Allan D Kirk 1 , M Louise Markert 5 6
Affiliations
1 Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
2 Division of Laboratory Animal Resources, Duke University, Durham, North Carolina, USA.
3 Department of Pathology, Emory University, Atlanta, Georgia, USA.
4 Department of Biostatistics and Bioinformatics.
5 Department of Immunology, and.
6 Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA.
PMID: 32352934
PMCID: PMC7308047
DOI: 10.1172/jci.insight.129983
** Their Conflict of Interest Statement:
Conflict of interest statement **
"Conflict of interest: Funding was obtained for this study in part from Enzyvant. MLM developed the technology of thymus transplantation, which has been licensed to Enzyvant. MLM has received royalties from Enzyvant. Portions of MLM’s and her research team’s salaries are being paid by the funding from Enzyvant. If the technology is commercially successful in the future, MLM and Duke may benefit financially."
**The company Enzyvant**
https://www.enzyvantconnect.com
** A news announcement **
Therapeutics, Inc. and Altavant Sciences, Inc., both wholly owned subsidiaries of the global biopharmaceutical giant Sumitovant Biopharma Ltd., today announced a merger to form a North Carolina-based biopharmaceutical company focused on delivering life-altering therapies for people with rare diseases.
The combined company retains the name Enzyvant, a company that got its start in 2016 in Durham, with a history of Triangle collaboration by manufacturing its unique products in facilities at Duke University.